Stay updated on Pembrolizumab as AML Post-Remission Treatment Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab as AML Post-Remission Treatment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab as AML Post-Remission Treatment Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a Locations section listing Pennsylvania as a study site. Removed the HHS Vulnerability Disclosure link and updated the page revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-22T23:53:38.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2 on the page, an internal version update that does not modify study content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:22:18.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.1 replaces v3.2.0. The update appears to be a site version change and does not affect the study information.
    Difference
    0.1%
    Check dated 2025-11-24T11:12:00.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The Notice about lapse in government funding and operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:09:26.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    No changes to core study content such as eligibility, outcomes, or treatment schedule were observed on the Study Details page for NCT02708641. The observed differences appear to be minor formatting/layout adjustments that do not affect the study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T00:47:02.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-05T05:10:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab as AML Post-Remission Treatment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab as AML Post-Remission Treatment Clinical Trial page.